NuGen Announces Non-Binding LOI to Acquire Sol-Millennium Canada
Toronto, Ontario--(Newsfile Corp. - August 6, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") is pleased to announce it has entered a non-binding letter of intent ("LOI") with Sol-Millennium Medical HK Limited ("SolM HK"), the sole shareholder of Sol-Millenium Canada Inc. ("SolM"), dated August 5, 2026 to acquire all of the issued and outstanding common shares of SolM (the "Proposed Transaction"). Each party is curre
Healthcare and Hospitals, Pharmaceuticals, Health
2026-08-06 8:07 AM EDT | NuGen Medical Devices Inc.
Adia Med to Host Dinner for Physicians at Christner's Steakhouse on August 5 to Discuss Clinical Studies and Collaboration Opportunities
Winter Park, Florida--(Newsfile Corp. - August 5, 2026) - Adia Med Inc. (OTCQB: ADIA), a regenerative medicine company focused on stem cell therapies and biologics, today announced that it will host a private dinner for physicians and investors on Wednesday, August 5, 2026, at 7:00 PM at Christner's Steakhouse.
Healthcare and Hospitals, Health
2026-08-05 4:30 PM EDT | Adia Med Inc.
HEALWELL AI Announces Conference Call for Second Quarter 2026 Financial Results on August 7, 2026
Toronto, Ontario--(Newsfile Corp. - August 4, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative care, is pleased to announce the Company will release its Fiscal Second Quarter 2026 financial results for t
Technology, Healthcare and Hospitals
2026-08-04 4:00 PM EDT | HEALWELL AI
TelyRx Launches New Brand and Digital Experience Inspired by Patient Feedback
Clearwater, Florida--(Newsfile Corp. - August 4, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF), a technology-enabled healthcare and digital pharmacy platform, today announced the launch of its new brand platform and digital experience, designed around the needs of modern patients. Shaped by insights gathered from patients over the past two years, the launch represents a significant investment in building a healthcare bra
Healthcare and Hospitals, Health
2026-08-04 7:30 AM EDT | TelyRx
Elite Pharmaceuticals Announces Commercial Launch of Generic Requip XL
Northvale, New Jersey--(Newsfile Corp. - August 4, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, today announced that the company has launched Elite's generic version of Requip XL® (Ropinirole Extended-Release Tablets USP), with strengths of 2 mg, 4 mg, 6 mg, 8 mg, and 12 mg tablets. Ropinirole belongs to a class of drugs known as a non-ergoline dopamine agonist used to treat P
Healthcare and Hospitals, Pharmaceuticals, Health
2026-08-04 7:00 AM EDT | Elite Pharmaceuticals, Inc.
Theralase(R) Engages Global One Media to Expand Global Investor Awareness
Toronto, Ontario--(Newsfile Corp. - August 4, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the research and development of energy-activated small molecules for the safe and effective destruction of cancer, bacteria and viruses, is pleased to announce that it has engaged Global One Media Group Pte. Ltd. ("Global One Media") to provide digital
Technology, Biotechnology, Healthcare and Hospitals, Pharmaceuticals
2026-08-04 7:00 AM EDT | Theralase Technologies Inc.
WELL Health Strengthens Executive Leadership Team with Appointments of Loreto Grimaldi as Chief Legal Officer and Kaytek Przybylski as Chief Digital & Information Officer
WELL appoints accomplished legal and business executive Loreto Grimaldi as Chief Legal Officer to lead legal, compliance, governance, risk management and M&A activities across the organization. Seasoned technology and digital transformation leader Kaytek Przybylski joins WELL as Chief Digital & Information Officer to lead enterprise technology, digital transformation, data, AI, and cybersecurity and technology shared services strategy.
Technology, Computer Software, Healthcare and Hospitals, Health
2026-08-04 6:30 AM EDT | WELL Health Technologies Corp.
WELL Health to Announce Second Quarter 2026 Financial Results on August 6, 2026
Vancouver, British Columbia--(Newsfile Corp. - August 4, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that the Company will release its Fiscal Second Quarter 2026 financial results for the period ended June 30, 2026, after market close on Thursd
Technology, Computer Software, Healthcare and Hospitals, Health
2026-08-04 6:00 AM EDT | WELL Health Technologies Corp.
BioMark Diagnostics Endorses Global Call for Equitable Access to Early Screening on 2026 World Lung Cancer Day
Vancouver, British Columbia--(Newsfile Corp. - July 31, 2026) - As the global healthcare community unites on August 1st to observe World Lung Cancer Day, BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark" or the "Company") proudly aligns with leading international healthcare organizations demanding equal access to early detection by developing simple, accessible blood testing that empowers patients and physicians with critical diagnostic insights when it matter
Technology, Biotechnology, Healthcare and Hospitals
2026-07-31 8:30 AM EDT | BioMark Diagnostics, Inc.
WELL Health Subsidiary WELLSTAR Closes C$50 Million Financing Transaction Ahead of Planned TSXV Listing
Vancouver, British Columbia--(Newsfile Corp. - July 31, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL"), a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that its subsidiary, WELLSTAR Technologies Corp. ("WELLSTAR"), has closed a financing transaction for aggregate gross proceeds of C$50 million (the "Financing
Technology, Computer Software, Healthcare and Hospitals, Health
2026-07-31 8:17 AM EDT | WELL Health Technologies Corp.
Jack Nathan Medical Corp. Announces Board Changes and Corporate Update
Toronto, Ontario--(Newsfile Corp. - July 31, 2026) - Jack Nathan Medical Corp. (TSXV: JNH) (OTC Pink: JNHMF) ("Jack Nathan" or the "Company") announces that Blake Lyon, Chairman of the Board of Directors, and Anthony DeCristofaro, Director, have resigned from the Board of Directors of the Company (the "Board"), effective July 31, 2026. Mr. Lyon and Mr. DeCristofaro have each served the Company for many years and have contributed significant time, leadership and experience throughout the
Healthcare and Hospitals, Retail, Health
2026-07-31 6:00 AM EDT | Jack Nathan Medical Corp.
Medexus Schedules First Fiscal Quarter 2027 Conference Call
Ontario and Chicago, Illinois--(Newsfile Corp. - July 30, 2026) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Tuesday, August 11, 2026 to discuss Medexus's results for its first fiscal quarter ended June 30, 2026. Medexus expects to file its financial statements and MD&A after markets close on August 10, 2026. To participate in the call, please dial the following numbers:
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-07-30 5:30 PM EDT | Medexus Pharmaceuticals Inc.
Richards Group Inc. Announces 2026 Second Quarter Results: Revenue Growth of 5% Primarily on Acquisitions; Gross Margins up 18%
Toronto, Ontario--(Newsfile Corp. - July 30, 2026) - Richards Group Inc. (TSX: RIC) (the "Company") announced today results for the quarter ended June 30, 2026. Second Quarter 2026 Highlights: Revenue contributions from acquisitions including DermapenWorld (June 2025) and PharmaSystems (May 2026) drove overall increase of 5.2%. Organic Healthcare revenue up 7.3%, representing a solid q
Healthcare and Hospitals, Household / Consumer / Cosmetics, Pharmaceuticals
2026-07-30 5:00 PM EDT | Richards Group Inc.
NewOrg Management System to Launch Its Biggest Update Ever, Reshaping How Nonprofits Manage Data
Washington, D.C.--(Newsfile Corp. - July 30, 2026) - NewOrg Management System, a cloud-based data and case management platform built for nonprofits, human services organizations, and government programs across the United States and Canada, today announced the largest platform update in the company's history. Beginning August 1, 2026, eight new capabilities will roll out across the platform, spanning artificial intelligence, security, and day-to-day operations. The update includes new AI
Computer Software, Healthcare and Hospitals, Housing, Aboriginal / Indigenous
2026-07-30 12:00 PM EDT | NewOrg Management System Inc
Bachem Confirms Growth and Expects a Strong Second Half 2026
Bubendorf, Switzerland--(Newsfile Corp. - July 30, 2026) - Ad hoc announcement pursuant to Art. 53 LR Media Release Group sales grew to CHF 326.4 million (+4.3% compared to the prior-year period, +7.3% in local currencies). EBITDA amounted to CHF 82.8 million (-9.0% compared to the prior-year period, -4.2% in local currencies) with a margin of 25.4% (prior-year period: 29.1%).
Biotechnology, Chemical, Healthcare and Hospitals, Pharmaceuticals
2026-07-30 12:56 AM EDT | Bachem Holding AG
CareRx Announces Q3 2026 Dividend
Toronto, Ontario--(Newsfile Corp. - July 29, 2026) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and other congregate care communities, today announced that the Company's Board of Directors has declared a dividend of CAD$0.022 per outstanding common share of the Company ("Common Shares"), payable on October 8, 2026, to holders of record of Common Shares as of the close of business on Septembe
2026-07-29 6:20 PM EDT | CareRx Corporation
CareRx Reports Results for the Second Quarter of 2026
Toronto, Ontario--(Newsfile Corp. - July 29, 2026) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and other congregate care communities, today reported its financial results for the second quarter ended June 30, 2026. Highlights for the Second Quarter of 2026 Average Beds Serviced1 increased to 91,719 in Q2 2026 from 90,048 Averag
2026-07-29 6:20 PM EDT | CareRx Corporation
Adia Med Completes Phase 1 and Formally Launches Phase 2 of Autism Spectrum Disorder Clinical Study
Winter Park, Florida--(Newsfile Corp. - July 29, 2026) - Adia Med Inc. (OTCQB: ADIA) today announced two distinct milestones in its Autism Spectrum Disorder (ASD) clinical research study (ClinicalTrials.gov Identifier: NCT07304440): the completion of Phase 1 treatment for the study's first cohort of children, and the formal launch of Phase 2 of the study. Separately, the company confirmed that a new cohort of 30 children will begin its own Phase 1 treatment on October 1, 2026, as part of the
Healthcare and Hospitals, Health
2026-07-29 6:00 AM EDT | Adia Med Inc.
Launchit Solutions and Privacy Horizon Partner to Help Canadian Health Tech Companies Build, Govern, and Scale with Confidence
Toronto, Ontario--(Newsfile Corp. - July 28, 2026) - Launchit Solutions and Privacy Horizon today announced a strategic partnership that gives Canadian health tech startups and scale-ups coordinated access to healthcare software development, Canadian cloud infrastructure, data governance, privacy and security readiness, and responsible AI governance. Bringing together more than 40 years of combined experience across healthcare, technology, privacy, cybersecurity, and governance, the partnersh
Technology, Computer Software, Healthcare and Hospitals
2026-07-28 10:00 AM EDT | Launchit Solutions Inc.
NuGen Adds to Core Patent Portfolio for Future Needle-Free Platforms
Toronto, Ontario--(Newsfile Corp. - July 27, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle-free drug delivery, today announced the filing of two additional patent applications supporting its current patent portfolio. The new applications focus on high-efficiency spring charging technology and automatic dose-establishment technology. Together with previously announced patent applications relating to the Company's dual-spring
Healthcare and Hospitals, Pharmaceuticals, Health
2026-07-27 5:15 PM EDT | NuGen Medical Devices Inc.